Clinical trials sponsored by Haukeland University Hospital

Phase breakdown

Conditions studied

Recruiting trials led by Haukeland University Hospital

• A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care
  NCT06299189 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy
  NCT05388461 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity
  NCT07042672 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
  NCT07312110 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 11 locations
• Effectiveness of a Digital Application for Adolescents With Mild to Moderate Anxiety
  NCT06531980 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 16 Years · Sex: All (male and female) · 1 location
• Evaluating the Big Five Intervention in Norway
  NCT07151573 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years and older · Sex: All (male and female) · 4 locations
• Exercise Therapy in Mental Disorders-study
  NCT06313918 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years and older · Sex: All (male and female) · 1 location
• Improving Diagnostics and Care After First Seizure
  NCT06814665 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease
  NCT07741071 · Phase: Phase 2 · Ages: 50 Years to 85 Years · Sex: All (male and female) · 2 locations
• Neurobiological Markers of Treatment Response for Anxiety and OCD
  NCT05663489 · Phase: Not specified · Ages: 16 Years and older · Sex: All (male and female) · 1 location
• Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis
  NCT05740722 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Rituximab and Ocrelizumab in Serum With Multiple Sclerosis
  NCT06663111 · Phase: Not specified · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• The Key to Integrated Trauma Treatment in Psychosis Trial
  NCT06608706 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years and older · Sex: All (male and female) · 11 locations

Common questions

How many trials is Haukeland University Hospital recruiting for?

Haukeland University Hospital is the lead sponsor of 13 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.